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ABSTRACT
The consensus sequence of p53 is repeated half
sites of PuPuPuC(A/T)(A/T)GPyPyPy. GtAGCAttAGC
CCAGACATGTCC is a 14-3-3p promoter p53 regula-
tion site; the first core sequence is CAttAG, and the
second is CATG. Both mutants GtAGgAttAGCCCAG
ACATGTCC and GtAGCAttAGCCCAGACATcTCC
can be activated by p53 as a 1.5-fold half site. The
original p53 regulated site on the 14-3-3p promoter
is a whole site, and CATTAG is a functional core
sequence. The p53-binding affinity and the activity
of CATTAG were lower than for the mutant CATATG
core sequence. Wild-type p53 acts as a tetramer to
bind to the whole site; however, it also can bind to a
half site by one of its dimers. Wild-type p53 can only
bind to a half site with core sequence CATG but not
to CATATG. The 1.5-fold half site or whole site with
core sequence CATATG can be bound by wild-type
p53. A p53 mutant, A344, forms dimeric p53; it can
only bind to CATG, and not to CATATG. Therefore,
tetrameric and dimeric p53 can bind to a two-base
A/T gap core sequence, but only tetrameric p53 can
bind to a four-base A/T gap core sequence.
INTRODUCTION
p53 is a key regulator of the cell cycle. After DNA
damage, p53 can be activated to block cell-cycle progres-
sion and mediate multiple check points. The p53 target
genes, p21 and 14-3-3 , can be induced by activated p53
to arrest the G1-to-S phase and G2-to-M phase of the cell
cycle, respectively (1,2). The p53 consensus sequence is
10-bp repeat of PuPuPuC(A/T)(A/T)GPyPyPy, separated
by a spacer with up to 13 bases (3). C(A/T)(A/T)G is the
core sequence, and the purine (pu) and pyrimidine (py)
bases comprise the ﬂanking sequence (Figure 1). The
whole p53-binding sequence is the 10-base direct repeated
sequence. Only 10 and 5 bases comprise the half site and
quarter site of the p53-binding site, respectively. The
p53-binding sequence with a half site plus a quarter site
is equal to 1.5-fold of the p53 half site (4). A half site of
the p53-binding site possesses p53-binding aﬃnity (4);
however, it can only be activated by p53 in a sequence-
speciﬁc manner or with other required cofactors (5–7).
About 1.5-fold of the p53 half site can be activated
by p53, but its activity is much lower than for the whole
p53-binding site (5,7). Both p21 and 14-3-3  have two p53
consensus sequences on their promoter (8). The p21 pro-
moter at 50 site one (GAACATGTCCcAACATGTTg)
and 30 site two (GAagAAGaCTGGGCATGTCT) can
be activated by p53. The 14-3-3s promoter 30 site two
(GtAGCAttAGCCCAGACATGTCC) can be activated
by p53 but not that at 50 site one (AGGCATGTgCcAcC
ATGCCC) (9). However, the p21 and 14-3-3s promoter
p53-binding sites presented some mismatched bases (the
lowercase letters note the mismatch bases). There are three
mismatch bases in the ﬂanking sequence of the
p53-binding site in 14-3-3s site one, but only one mis-
match base in 14-3-3s site two. There are two bases of
the A/T gap in the core sequence of the p53-binding site
in p21 site one and 14-3-3s site one, but there are four
bases in 14-3-3s site two. Although the entire p53 consen-
sus sequence comprises the whole p53-binding site, a
1.5-fold half site of the p53-binding site could be activated
by p53, similar to p21 site two (7). In order to identify
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a whole site or a 1.5-fold half site, diﬀerent mutant core
sequences were cloned and tested for their functional
activities. Interestingly, the p53-binding site on the
14-3-3s promoter contained four bases of the A/T gap
CATTAG core sequence. It diﬀered from the p53 consen-
sus by two bases of A/T gap CATG core sequence. To
clarify how many bases of the A/T gap in the p53 core
sequence are tolerant for p53-activating genes, basic
promoter vectors with diﬀerent A/T gap p53 response
elements were constructed. The promoter activities and
-binding aﬃnities were measured in our experiments.
p53 binding to the whole p53 response element is tetra-
meric and it can bind to the p53 half site by one of its
dimers. A dimeric form of p53 mutant p53A344 also can
bind to the p53 half site (4). To understand the four-base
A/T gap CATTAG p53 core sequence binding character
to p53, a dimeric form of p53 mutant p53A344 and a
tetrameric p53 were used in a DNA aﬃnity puriﬁcation
assay (DAPA).
MATERIALS AND METHODS
Construction of reporter vectors withp53
response element sequence
Oligonucleotides (20–34bp) with p53 response element
sequences were synthesized and annealed to SmaI-digested
pGL3 promoter vector (Promega). The vector and insert
were ligated using a 1:4500 ratio at 228C for 15min then
transformed at 378C overnight. The positive clones were
checked by DNA sequencing.
Luciferase activity assay
H1299 cells were grown in 12-well tissue culture dishes to
60% conﬂuence and then cotransfected with 0.5mgo f
pcDNA 3.0 (Invitrogen), pcDNA 3.0 p53, pcDNA 3.0
p53F46, or pcDNA 3.0 p53364–393 in the presence of
0.5mg of pGL3 promoter ﬁreﬂy luciferase (Promega) or
pGL3 promoter with a p53 response element sequence and
10ng of pCMV renilla luciferase plasmids (Promega).
Twenty-four hours post-transfection, cells were harvested
in 0.25ml reporter lysis buﬀer and were subjected to a
dual luciferase assay according to the manufacturer’s pro-
tocol (Dual-Luciferase Reporter Assay System, Promega).
Fireﬂy luciferase activity was normalized to renilla lucife-
rase activity and data are presented as the mean   SD
of three independent experiments, each performed in
triplicate.
P53 mutants expression vectorconstruct
The p53F46, p53364–393, p53A344364–393 and
p53A344 point mutations or deletion clones were
created by site-directed mutagenesis according to the man-
ufacturer’s instructions (Phusion Site-Directed Mutagen-
esis Kit, Finnzymes). p53F46 was created using the
following primers: TCCCGGACGATATTGAACAA
TGG and ACAGCATCAAATCATCCATTGCTTGG.
p53364-393 was created using the following primers: T
GAGGATCCACTAGTAACGGCCGC and CCTGCTC
CCCCCTGGCTC. p53A344364–393 and p53A344 were
created using the following primers: CAAGGCCTCATT
CGCCTCTCGGAACATC and GAACTCAAGGATG
CCCAGGCTGG. All constructs were checked by DNA
sequencing.
DNA affinity purification assay
Nuclear extract (100mg) was prepared from 5 10
6 H1299
cells transfected with 16mg of p53364–393,
p53A344364–393 or p53A344 plasmid. The nuclear
extracts were precleared by incubation with 40ml strepta-
vidin–agarose beads (4%) with a 50% slurry at 48C for 1h
with rotation. They were then centrifuged at 4000 g for
1min at 48C. The supernatant was collected as the pre-
cleared nuclear extract. The binding reaction was per-
formed by mixing the precleared nuclear extract proteins
with the annealing probe (0.3nmol), 5  binding buﬀer
[100mM HEPES; pH 7.6, 5mM EDTA, 50mM
(NH4)2SO4, 5mM DTT, 1% Tween 20 (w/v), 150mM
KCl], 10ml sonicated salmon sperm DNA (1mg/ml) and
the 40ml streptavidin–agarose beads (4%) with a 50%
slurry in 1ml. This was incubated at room temperature
for 1h with rotation. The beads were washed three times
with 1  PBS. The binding proteins were eluted with 20ml
of 5  loading dye, then separated by sodium dodecylsul-
fate polyacrylamide gel electrophoresis (SDS–PAGE)
followed by western blot analysis, and were probed with
p53 antibody (p53 Ab-2, Lab Vision). Nuclear extract
(10mg) was mixed with 20ml5   loading dye as the 10%
‘input’ sample. To diﬀerentiate binding aﬃnities of
various p53 proteins to the p53 response element, either
the low or high dosage of nuclear extract was used in the
DAPA assay. The 30 or 300mg of nuclear extract was used
in each binding reaction, with 10mg of nuclear extract
used as an ‘input’ loading control, which was 33% or
3.3% of the sample, respectively.
RESULTS
The original p53-regulated site on the 14-3-3ppromoter
isap53 wholesite response element, and CATTAG
isafunctional coresequence
Designed p53 response element sequences were con-
structed in the pGL3 promoter digested by SmaI
(Figure 2A). These designed p53 response element
sequences with core sequence mutants are listed in
Figure 2B. The whole p53 site is as a perfect match
sequence for the p53 consensus sequence (p53 2 ), and
the fourth quarter with a TcTCT mutation is a 1.5-fold
half site of the p53-binding site (p53 1.5 ). Deletion of
the ﬁrst and second quarter produces a half site of the
p53-binding site (p53 1 ). After cotransfection with the
p53 expression vector, the reporter activity of the whole
site (p53 2 ) is higher than that of the 1.5-fold half site
(p53 1.5 ), but there is no activity in a half site (p53 1 )
construct compared to that for the pGL3 promoter vector
only (pr) (Figure 2C). The p53 response element on the
14-3-3s promoter, its ﬁrst half site with a four-base A/T
gap in the core sequence is diﬀerent from the common p53
core sequence with a two-base A/T gap (2,7), may have
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response element sequence is a 1.5-fold half site similar
to that of p53 1.5 . Therefore, the ﬁrst-quarter mutation
(14-3-3 m1) activities were the same as for the full 14-3-3s
sequence, and the fourth-quarter mutation (14-3-3 m4)
had no activity. The promoter activity of the full
14-3-3s p53 response element sequence is higher than
14-3-3 m1. The 14-3-3 m1 is also higher than 14-3-3 m4
activity. The ﬁrst- and second-quarter double-deleted
mutants 14-3-3 d12 is no promoter activity at all
(Figure 2C). Therefore, the original p53-regulated site on
the 14-3-3s promoter acts as a whole site, with CATTAG
as a functional core sequence.
Four-baseA/Tgapactsasp53coresequenceresponseelement
To evaluate if the A/T base gap in the p53 core sequence
can be a functional core sequence of the p53 response
element. One to ﬁve A/T base gaps were synthesized and
cloned into 1.5-fold half sites (Figure 3A). The promoter
activities were examined by luciferase activity assay. Only
two- and four-base gaps can be activated by p53
(Figure 2B). When comparing two-base A/T gap core
sequences with four-base A/T gaps, the activities were
higher in two-base A/T gaps than in four-base A/T
gaps. However, the 4A/T base gap CATATG activity
was higher than CATTAG (Figure 3B).
The whole p53 response element sequence activation by
p53 was higher than for the 1.5-fold half site (5). Is the
four-base A/T gap core sequence as functional in the
whole site as in the 1.5-fold half site as previously demon-
strated? The four-base A/T gap mutants in the whole p53
response element sequence were cloned, and the promoter
activity was examined by a luciferase activity assay
(Figure 4A). The results indicated that the core CATAT
G activity activated by p53 is higher than for CATTAG in
both the whole site and the 1.5-fold half site (Figure 4B).
Two super p53 mutants, p53F46 and p53364–393
(10,11), also can activate the p53 whole site with the CA
TATG core sequence, even more so than wild-type p53
(Figure 5).
Tetrameric and dimeric p53 canbind tothe two-base
A/T gapcore sequence,but onlytetrameric p53 can
bind tothe four-base A/Tgap coresequence
By using DAPA to investigate the p53-binding character
to a two-base A/T core sequence and to a four-base
A
B
C
Figure 2. The 14-3-3s promoter p53 response element activity assay.
(A) Double strands of oligonucleotides with designed p53 response ele-
ment sequences were cloned to the SmaI site of the pGL3 promoter
vector with a luciferase reporter gene. (B) Designed p53 response ele-
ment sequences. p53 2 : p53 whole site; p53 1.5 : 1.5-fold p53 of half
site with fourth-quarter site mutation; p53 1 : p53 half site with
deletion of ﬁrst and second quarters; 14-3-3s: p53 response element
of 14-3-3s promoter; 14-3-3sm1: ﬁrst-quarter mutation; 14-3-3sm4:
fourth-quarter mutation; 14-3-3sd12: ﬁrst- and second-quarter dele-
tions. (C) Designed promoters were cotransfected with p53 expression
vectors into H1299 cells, and the folds of luciferase promoter activity
compared to the pcDNA3.0 as 1. The activity of p53 2  is higher than
p53 1.5 , and the activity of p53 1  is similar to pGL3 promoter
vector only (pr). The p53 induced activity pattern of 14-3-3s promoter
constructs is the highest from 14-3-3s > 14-3-3sm1 > 14-3-3sm4.
There was no activity in the 14-3-3sd12 mutant construct.
Figure 1. The p53 consensus sequence. The purine (R) and pyrimidine
(Y) bases comprise the ﬂanking sequence. C(A/T)(A/T)G is the core
sequence, and the (A/T)(A/T) within the core sequence is an A/T gap.
The whole site is 20 bases with a ten-base direct repeat as a 2  half
site, and each 10 bases are a 1  half site. Each ﬁve bases are quarter
sites. A whole site with a core sequence C to G mutation within the
ﬁrst quarter site is a 1.5  half site, with a core sequence G to C
mutation within the fourth quarter site is another 1.5  half site.
1986 Nucleic Acids Research, 2009, Vol. 37,No. 6A/T core sequence (Figure 6B), three p53 mutants,
p53364–393, p53A344364–393 and p53A344, were
constructed and expressed in H1299 cells (Figure 6A).
The p53364–393 mutant, consisting of the last 30
amino acids of a C-terminal deletion p53 mutant, avoided
non-speciﬁc binding and sliding-oﬀ eﬀects (5,11). First,
50-labeled biotin probes with 2–4 gaps of A/T bases in a
p53 half-site sequence were used to examine the binding
character of p53364–393. The results indicated that
p53364–393 can only bind to two-base-gap CATG
core sequences but not to three-base-gap CATAG, four-
base-gap CATATG, or CATTAG core sequences
(Figure 6C). Surprisingly, with probes with two to four
gaps of A/T bases in a 1.5-fold p53 half-site sequence,
p53364-393 not only can bind to two-base-gap CATG,
but also can bind to four-base-gap CATATG or CATTA
G core sequences (Figure 6D). However, p53364–393
cannot bind to a three-base-gap CATAG core sequence.
The binding aﬃnity patterns in DAPA correlated to the
function assay of the sequence activated by p53
(Figures 3B and 6D). The p53-binding aﬃnity and activity
of two four-base-gap CATATG and CATTAG core
sequences were diﬀerent; CATATG-binding aﬃnity and
activity was higher than for CATTAG (Figures 3B
and 6D). p53364–393 can bind two-base-gap CATG in
both p53 half sites and 1.5-fold half sites as probes, but it
can only bind to four-base-gap CATATG or CATTAG
core sequences in 1.5-fold p53 half sites, not to p53 half
sites (Figure 6C and D). p53364–393 can also bind to a
p53 whole site with four-base A/T gaps in each core
sequence (Figure 6E). To evaluate the binding-pattern
discrepancy between two-base-gap CATG to four-base-
gap CATATG, perhaps due to dimeric or tetrameric-
binding character diﬀerences, dimeric p53A344364–393
and p53A344 were used (4,12). The DAPA results
show that both dimeric p53 mutants, p53A344 and
p53A344364–393, can only bind to two-base-gap
CATG core sequences in a p53 half site, but cannot bind
to four-base-gap CATATG core sequences in a 1.5-fold or
2-fold half site (Figure 6F and G). Because of weak binding
of dimeric p53A344364–393 to the two-base-gap CATG
Figure 4. Promoter activity assay for four-base A/T gap core sequence
with p53 2X and 1.5X-fold p53 half site. (A) Designed four-base A/T
gap core sequence p53 response element constructs and its mutants: 2 
CATATG: whole site with CATATG core sequence; 2  CATTAG:
whole site with CATTAG core sequence; m1-4g CATATG: mutation
of ﬁrst-quarter site with CATATG core sequence; m1-4g CATTAG:
mutation of ﬁrst-quarter site with CATTAG core sequence; and d12
is a negative control. (B) Designed four-base A/T gap core sequence
p53 response element and mutant promoter constructs were co-trans-
fected with p53 expression vectors into H1299 cells. The folds induction
of luciferase promoter activity compared to the pcDNA3.0 as 1. Both 2-
and 1.5-fold half-site core sequences of CATATG promoter activity
were higher than CATTAG core sequence.
Figure 3. The promoter activity in various A/T gap core sequences of
p53 promoter response element. (A) Designed various A/T gap core
sequence p53 response elements. m4-1g CAG: fourth quarter-site muta-
tion and ﬁrst half-site core sequence CAG. m4-2g CATG, m4-3g
CATAG, m4-4g CATTAG, m4-4g CATATG, m4-5g CATATAG and
d12 as negative control as in Figure 2B. (B) Designed various A/T
gap core sequences of p53 promoter response element constructs were
cotransfected with p53 expression vector into H1299 cells, and
the luciferase promoter activity was compared to pcDNA3.0 as 1.
The activity order is: m4-2g CATG > m4-4g CATATG > m4-4g
CATTAG. No activity could be detected in m4-1g CAG, m4-3g
CATAG, m4-5g CATATAG or d12.
Figure 5. Super p53 mutant activation of four-base A/T gap core
sequences of p53 response element. Super p53 expression vector
p53F46 or p53364-393 was co-transfected with four-base A/T core
sequence p53 promoter response elements into H1299 cells, and the
folds of luciferase promoters activity induction compared to the
pcDNA3.0 as 1. Both super p53 mutants can activate with higher activ-
ity than wild-type p53 at the four-base A/T gap core sequence of p53
promoter response element.
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dosages of nuclear extract were used in the DAPA reaction
to compare the aﬃnity of the dimeric and the tetrameric
p53 binding with two- or four- base-gap CATG core
sequences. In the low-dosage DAPA assay, dimeric
p53A344364–393 was not detected in two-base-gap
CATG core sequences as a p53 half site, but tetrameric
p53364–393 bound both to two-base-gap CATG core
sequences in a p53 half site and four-base-gap CATATG
core sequences in a p53 whole site (Figure 6H). In the
high-dosage DAPA assay, dimeric p53A344364–393
bound to two-base-gap CATG core sequences in a p53
half site but could not bind to four-base-gap CATATG
core sequences in 2-fold half site (Figure 6I). According
to the results, we believed that the four-base A/T gap can
be bound only by tetrameric p53, but not by dimeric p53.
DISCUSSION
Based on the functional assay and DAPA results, except
for the two-base A/T gap core sequence of the p53
response element, the four-base A/T gap core sequence
also acts as a p53 response element. The p53 target gene,
the 14-3-3s core sequence of p53 response element
GtAGCATTAGCCCAGACATGTCC, is thought to be
a whole p53 response element. We tested two four-base
A/T gap variant core sequences of p53 response elements,
CATATG and CATTAG. Both p53-binding aﬃnity and
activity of CATATG were higher than for CATTAG
(Figures 3B, 4B and 6D). It has been demonstrated that
two-base A/T gap core sequences in diﬀerent A/T arrays
had diﬀerent responses for p53 activation (13). The
p53-induced core sequence activity with AT or TA was
higher than for AA or TT. It may explain how the four-
base A/T gap CATATG activity was higher than for CAT
TAG in our experiments. However, A/T arrays in the core
sequence with four-base gaps may have 16 variants;
diﬀerent A/T arrays in the core sequence with four-base
gaps may have diﬀerent p53 responses. It needs further
investigation.
Sauer et al. (11) reported p53 binding to p53 response
elements with the electrophoretic mobility shift assay
(EMSA). An oligonucleotide probe less than 66bp may
cause non-speciﬁc binding and sliding-oﬀ to reduce spe-
ciﬁc binding. Once the C-terminal 30 amino acids of p53
were deleted, the speciﬁc binding aﬃnity was recovered
(11). For DAPA, from our designed probes of 20–34bp
Figure 6. p53-binding character to various A/T core sequences of p53
response element by DAPA assay (A) Diagrams of the p53 protein
structure and oligomerization mutant constructs: There are four
major functional domains within 393 amino-acid residues; N-terminal
transactivation domain, middle DNA-binding core domain, C-terminal
oligomerization and non-speciﬁc binding domains. p53364–393: tetra-
meric form of p53 with non-speciﬁc binding domain deletion.
p53A344364–393: dimeric form of p53 with non-speciﬁc binding
domain deletion. p53A344: dimeric form p53. (B) Oligomerization
mutants of p53 expression vectors were transfected into H1299 cells.
After 48h incubation, the nuclear proteins were extracted and
incubated with various probes in a DAPA assay. Various A/T core
sequences with p53 response element designed primers as probes. One
hundred micrograms of nuclear extracts were used in C, D, E, F and G;
30mg of nuclear extracts were used in H; 300mg of nuclear extracts
were used in I. All of the input samples were 10mg of nuclear extract
as 10% loading control in C, D, E, F and G; 33% in H; 3.3% in I. (C)
The tetrameric form of p53364–393 can bind to two-base A/T gap
CATG core sequences but cannot bind to three-base A/T gap CATAG,
four-base A/T gap CATATG, or CATTAG core sequences when the
probes as the half site. (D) The tetrameric form of p53364–393 can
bind to two-base A/T gap CATG, four-base A/T gap CATATG and
CATTAG core sequences but cannot bind to three-base A/T gap
CATAG core sequences when the probe was the 1.5-fold half site.
Among four-base A/T gap core sequences, the p53-binding aﬃnity in
CATATG was higher than CATTAG. (E) The tetrameric form of
p53364–393 can bind to four-base A/T gap CATATG core sequences
when the probes were the 1.5-fold half site or the 2-fold half site.
(F) The dimeric form of p53A344364–393 can bind to the two-base
A/T gap CATG core sequence when the probe was the half site but
cannot bind to four-base A/T gap CATATG core sequences even with
probes as the 1.5-fold half site or 2-fold half site. (G) The other p53
mutant, dimeric form of p53A344, can bind to two-base A/T gap
CATG core sequences when the probe as the half site. (H)
Tetrameric p53364–393 can bind to two-base A/T gap CATG in a
half site or four-base A/T gap CATATG in a 2-fold half site, but
dimeric p53A344364–393 can not be detected in all reactions with
low nuclear extract samples. (I) Both tetrameric p53364–393 and
dimeric p53A344364–393 can bind to two-base A/T gap CATG
when the probe was a half site. However, tetrameric p53364–393
can bind to four-base A/T gap CATATG when the probe was a
2-fold half site, but dimeric p53A344364–393 lost it binding aﬃnity
at all even reaction with high nuclear extract sample.
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acter of 2–4-base A/T gap core sequences of p53 response
elements, the 30 amino-acid C-terminal deletion mutant,
p53364–393, was chosen. Tetrameric p53 can bind to
two-base A/T gap core sequences of p53 at half sites
and 1.5-fold half sites, but it can only bind to four-base
A/T gap core sequences of p53 1.5-fold half sites and
whole sites, and not to half sites alone (Figure 6C, D
and E). The wild-type p53 normally bound to two-base
A/T core sequences of p53 2  half-site response elements
in a tetrameric manner (4,5). p53 can bind to two-base A/T
core p53 half-site sequences by one of its dimers and can
leave the other dimer free (4), but this binding pattern was
not observed in four-base A/T core sequence p53 half
sites. Three tetramerization-domain-deleted monomeric
p53 mutants can bind to two-base A/T core sequence
1.5-fold p53 half sites (5). We proposed that tetrameric
wild-type p53 can bind to 1.5-fold p53 half sites by three
of its monomers and can leave the other monomer free in
both two-base and four-base A/T core sequence p53 1.5 
half sites. Forfurther characterizationof thefour-baseA/T
gap core sequence of p53 response elements at 1.5  half
sites or whole sites that can only bind tetrameric p53
(Figure 6D and E), dimeric p53 mutant p53A344 and
p53A344364–393 were used in DAPA. Neither dimeric
p53 mutant can bind to four-base A/T gap p53 response
elements at 1.5-fold half sites and whole sites (Figure 6F
and G), its diﬀerent from two-base A/T gap core sequence
p53 half sites can bind dimeric p53 mutants (Figure 6F and
G). Therefore, dimeric p53 can only bind to two-base but
not to four-base A/T gap p53 response elements.
p53 is composed of an N-terminal transactivation
domain, a DNA-binding core domain and a C-terminal
oligomerization domain (Figure 6A) (14). The oligomeri-
zation domain is composed of a turn followed by a
b-sheet, a turn and an a-helix (15,16). The b-sheet has a
monomer dimerization motif, and the a-helix has a dimer–
dimer interface motif. The oligomerization domain of p53
is also involved in DNA binding to the supercoil DNA
and enhances core domain DNA-binding aﬃnity (17,18).
In our experiments, the dimeric p53A344364–393
mutant bound to two-base gap core sequences of the
p53 response element half site, but the aﬃnity was much
lower than for tetrameric p53364–393 (Figure 6I; 1 2g
AT compares to input). It is indicated that the a-helix
dimer–dimer interface of the p53 oligomerization
domain enhanced core domain DNA binding. With an
extended core sequence from two-base A/T gaps to four-
base A/T gaps, not dimeric p53, but only tetrameric p53
can bind to both 1.5-fold p53 half sites and p53 whole sites
(Figure 6E, F and G). Therefore, the a-helix dimer–dimer
interface of the p53 oligomerization domain seems neces-
sary for binding to four-base A/T core sequences of p53
response elements in both 1.5-fold p53 half sites and p53
whole sites (Figure 7).
According to McLure and Lee (4), the dissociation con-
stant (Kd) of tetrameric or dimeric p53 binding to the p53
whole site or half site varied. The binding Kd pattern was:
tetrameric to whole site < dimeric to whole site < tetra-
meric to half site < dimeric to half site (4). Therefore, the
highest p53-binding aﬃnity was tetrameric binding to
the whole site, followed by dimeric binding to the whole
site, tetrameric binding to the half site, and the lowest
p53-binding aﬃnity is dimeric binding to the half site.
There were similar results in our DAPA assay; the binding
aﬃnity of tetrameric p53364–393 was higher than
dimeric p53A344364–393 bound to two-base A/T gap
core sequence of the p53 half site (Figure 6I). Once the
four-base A/T gap core sequence was substituted for the
two-base A/T gap core sequence in the whole site, it could
be bound only by tetrameric p53364–393, but not by
dimeric p53A344364–393 (Figure 6I). Therefore, the
integrity of the tetrameric state of p53 is necessary for
p53 binding to the four-base A/T gap core sequence. It
has been indicated that several other factors in cells can
associate with the p53 oligomerization domain to aﬀect
the tetramerization state of p53. S100 family proteins
and apoptosis repressors with caspase recruitment
domains (ARC) can associate with the p53 oligomeriza-
tion domain to inhibit p53 tetramerization and to repress
the trans-activation function of p53 (19–23). The 14-3-3
family proteins can also associate with the p53 oligomer-
ization domain to enhance p53 tetramerization (24).
Therefore, the 14-3-3 family, S100 family and ARC may
be important regulators for inﬂuencing the aﬃnity and
activity of p53 through the core sequence with a four-
base A/T gap.
We identiﬁed a non-canonical p53 response element
and found that a four-base A/T gap core sequence can
Figure 7. Model for p53 protein molecule-binding pattern to various
A/T gap core sequences of the p53 response element. Wild-type p53
binds to a canonical p53 response element at the two-base A/T gap
core sequence p53 whole site in a tetrameric manner, and each of the
dimers binds to each p53 half site. Tetrameric wild-type p53 binds to
two-base A/T gap core sequence at 1.5-fold p53 half sites by three of its
monomers and leaves the other monomer free. p53 binds to two-base
A/T gap core sequence p53 half-site core sequences by one of its dimers
and leaves the other dimer free. Other binding patterns of p53 to a non-
canonical p53 response element at four-base A/T gap core sequence of
p53 response elements are similar to those of the two-base A/T gap
core sequence in both the p53 whole site and 1.5-fold half site, but p53
cannot bind to the four-base A/T gap core sequence p53 half site.
However, dimeric p53, p53A344,disrupting the dimer–dimer interface,
can bind to two-base A/T gap core sequence p53 half sites, but not to
four-base A/T gap core sequence p53 whole sites or 1.5-fold half sites.
Nucleic Acids Research,2009, Vol.37, No. 6 1989be activated by p53. Also, the diﬀerent A/T arrays in
a four-base A/T gap core sequence may aﬀect the
p53-binding aﬃnity and activation function. We also
clariﬁed that the p53-binding character for four-base
A/T gap core sequence is diﬀerent from the canonical
p53 response element.
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